APS

29th APS Annual Convention

Understanding and Managing Distress with Cannabis: Neuropsychiatric Comorbidity and Targets for Treatment

Sunday, May 28, 2017 · Boston, MA

Clinical Science

Cannabis is used for medicinal purposes but is also linked to neuropsychiatric problems, and this risk/benefit issue remains unresolved. This symposium will broaden the understanding of the relationships between cannabis, neuropsychiatric symptoms and mental illness, and discuss the utility of a cognitive target for intervention for problematic cannabis use.

Chairs & Discussants

  • Nehal VadhanChair
    Hofstra/Northwell
  • Nehal VadhanChair
    Northwell Health
  • Staci GruberCoChair
    Harvard Medical School
  • Staci GruberCoChair
    McLean Hospital
  • Alan BudneyDiscussant
    Geisel School of Medicine at Dartmouth College

Presentations

  1. Potential Mechanisms of Differential Response to Smoked Cannabis in Individuals at Clinical High-Risk for PsychosisNehal Vadhan
  2. Let’s be Blunt: Exploring the Impact of Recreational and Medical Cannabis UseStaci Gruber
  3. The Mediating Roles of Sleep and Coping Motives in Cannabis Use and Problems Among Returning Veterans with Posttraumatic Stress and Major Depressive DisordersJane Metrik
  4. Examining Cognitive Bias Modification As a Potential Treatment for Cannabis-Using YouthLindsay Squeglia